Ellipses Pharma a global drug development company focused on accelerating the development of new oncology treatments, today announces its intention to expedite further global clinical

Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for regenerating bone and managing infection in bone and soft

Agilent Technologies Inc.today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics, being held June 4 - 8 in Houston

Eikon Therapeutics, Inc., a biotechnology company that is advancing breakthrough therapeutics through the purposeful integration of engineering and science, today announced it has acquired

Crowell & Moring International is joining forces with Roche, TogetHER for Health, CAPED and Jhpiego to raise awareness about the surge of breast and cervical cancer cases in the Asia-Pacific

InDex Pharmaceuticals Holding AB today announced that a license agreement has been signed with Viatris Pharmaceutical Japan Inc.to register and commercialize cobitolimod in Japan

Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved ABRYSVO™ the company’s bivalent RSV prefusion F vaccine, for the prevention

MEI Pharma, Inc. today confirmed receipt of an unsolicited and non-binding proposal on May 23, 2023 from a group represented by Anson Advisors Inc. and Cable Car Capital LLC, as referenced

Aragen Life Sciences , a leading Contract Research and Development Organization, and FAR Biotech, a US-based, AI-driven, computational drug discovery company, have announced

Algiax Pharmaceuticals, today provided an update on its ongoing Phase 2a study with lead candidate AP-325 in patients with chronic neuropathic pain. As part of a planned mid-enrollment